Salmon Anemia Virus Antibody (16F4): sc-66102

Salmon Anemia Virus Antibody (16F4) is a mouse monoclonal IgG2a antibody that detects the Salmon Anemia Virus protein of Salmon Anemia Virus origin by western blotting (WB). Anti-Salmon Anemia Virus antibody (16F4) is available as the non-conjugated format. The Salmon Anemia Virus (SAV) is a significant pathogen responsible for infectious salmon anemia (ISA), a viral disease that poses a serious threat to Atlantic salmon (Salmo salar) populations, leading to severe anemia and high mortality rates in infected fish. SAV primarily targets the hematopoietic system, causing the destruction of red blood cells and resulting in symptoms such as pale gills and abnormal swimming behavior as fish struggle to obtain oxygen. SAV is an enveloped virus, measuring approximately 45 to 140 nm in diameter, and can be cultured in the Atlantic salmon head kidney (SHK1) cell line. SAV employs the endocytic pathway for cellular entry and possesses a receptor-destroying enzyme, which is a characteristic feature shared with other enveloped viruses, including the influenza virus. Understanding the structure and function of SAV is crucial for developing effective management strategies to mitigate the impact of ISA on aquaculture and wild fish populations. Salmon Anemia Virus monoclonal antibody (16F4) serves as a valuable tool for researchers studying the pathogenesis of this virus and its effects on salmon health.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Salmon Anemia Virus Antibody (16F4) References:

1. Comparison of lethal versus non-lethal sample sources for the detection of infectious salmon anemia virus (ISAV).  |  Giray, C., et al. 2005. Dis Aquat Organ. 66: 181-5. PMID: 16261932
2. Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses.  |  de Groot, RJ. 2006. Glycoconj J. 23: 59-72. PMID: 16575523
3. How specific MHC class I and class II combinations affect disease resistance against infectious salmon anaemia in Atlantic salmon (Salmo salar).  |  Kjøglum, S., et al. 2006. Fish Shellfish Immunol. 21: 431-41. PMID: 16616518
4. Detection of infectious haematopoietic necrosis virus and infectious salmon anaemia virus by molecular padlock amplification.  |  Millard, PJ., et al. 2006. J Fish Dis. 29: 201-13. PMID: 16635060
5. Retraction. Characterization of Chinhook head salmon embryo phenotypes of infectious salmon anemia virus by real-time RT-PCR.  |  Munir, K. 2006. J Vet Sci. 7: 307. PMID: 16871030
6. Promoters of type I interferon genes from Atlantic salmon contain two main regulatory regions.  |  Bergan, V., et al. 2006. FEBS J. 273: 3893-906. PMID: 16889635
7. In vivo correlates of infectious salmon anemia virus pathogenesis in fish.  |  Kibenge, FSB., et al. 2006. J Gen Virol. 87: 2645-2652. PMID: 16894204
8. Virus-like particles associated with heart and skeletal muscle inflammation (HSMI).  |  Watanabe, K., et al. 2006. Dis Aquat Organ. 70: 183-92. PMID: 16903229
9. Efficacy of emamectin benzoate against sea lice infestations of Atlantic salmon, Salmo salar L.: evaluation in the absence of an untreated contemporary control.  |  Gustafson, L., et al. 2006. J Fish Dis. 29: 621-7. PMID: 17026671